GPP

Great Point Partners Portfolio holdings

AUM $308M
1-Year Est. Return 183.85%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+183.85%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$308M
AUM Growth
+$68.9M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
42
New
Increased
Reduced
Closed

Top Buys

1
+$25.5M
2
+$21.1M
3
+$18M
4
RARE icon
Ultragenyx Pharmaceutical
RARE
+$9.87M
5
SLNO icon
Soleno Therapeutics
SLNO
+$9.6M

Top Sells

1
+$14.9M
2
+$12.7M
3
+$11.8M
4
CYTK icon
Cytokinetics
CYTK
+$8.24M
5
XENE icon
Xenon Pharmaceuticals
XENE
+$8.03M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SANA icon
26
Sana Biotechnology
SANA
$841M
$2.85M 0.92%
700,000
PHVS icon
27
Pharvaris
PHVS
$1.78B
$2.3M 0.75%
82,800
-72,305
AVTX icon
28
Avalo Therapeutics
AVTX
$317M
$2.26M 0.73%
+124,666
RZLT icon
29
Rezolute
RZLT
$304M
$2.25M 0.73%
951,809
-1,500,000
ABSI icon
30
Absci
ABSI
$368M
– –
-796,438
ABVX
31
Abivax
ABVX
$8.88B
– –
-150,000
AKRO
32
DELISTED
Akero Therapeutics
AKRO
– –
-103,848
ASND icon
33
Ascendis Pharma
ASND
$14B
– –
-75,000
CAPR icon
34
Capricor Therapeutics
CAPR
$1.83B
– –
0
CYTK icon
35
Cytokinetics
CYTK
$7.84B
– –
-150,000
DBVT
36
DBV Technologies
DBVT
$1.15B
– –
-378,594
HRMY icon
37
Harmony Biosciences
HRMY
$1.67B
– –
0
IONS icon
38
Ionis Pharmaceuticals
IONS
$12.4B
– –
-80,000
LEGN icon
39
Legend Biotech
LEGN
$3.74B
– –
-113,460
PLRX icon
40
Pliant Therapeutics
PLRX
$81.7M
– –
-850,000
TSHA icon
41
Taysha Gene Therapies
TSHA
$1.24B
– –
-1,500,000
XENE icon
42
Xenon Pharmaceuticals
XENE
$4.91B
– –
-200,000
1
2